These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 10494194)
1. [Patents on genes--ethics going astray]. Vigen T Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2798. PubMed ID: 10494194 [No Abstract] [Full Text] [Related]
2. [Going astray when it comes to gene patents]. Gogstad G Tidsskr Nor Laegeforen; 1999 Sep; 119(23):3475-6. PubMed ID: 10553350 [No Abstract] [Full Text] [Related]
3. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy. Paradise J Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928 [No Abstract] [Full Text] [Related]
5. [Revocation of the BRCA1 patents by the European Office of Patents: a victory over a rights abuse]. Stoppa-Lyonnet D; Lenoir G Bull Cancer; 2005 Apr; 92(4):410-1. PubMed ID: 15888396 [No Abstract] [Full Text] [Related]
7. Testing time for gene patents. Nature; 2010 Apr; 464(7291):957. PubMed ID: 20393513 [No Abstract] [Full Text] [Related]
8. Ethical aspects of patenting in biotechnology. Crespi RS Cancer Detect Prev; 1993; 17(2):323-7. PubMed ID: 8402720 [No Abstract] [Full Text] [Related]
9. Biotechnology patents: strategies for meeting economic and ethical concerns. Gold ER Nat Genet; 2002 Apr; 30(4):359. PubMed ID: 11925560 [No Abstract] [Full Text] [Related]
10. Biotechnology. Lawsuit challenges legal basis for patenting human genes. Marshall E Science; 2009 May; 324(5930):1000-1. PubMed ID: 19460975 [No Abstract] [Full Text] [Related]
11. Patents stalemate on biotechnology. Butler D Nature; 1994 Dec; 372(6505):393. PubMed ID: 7984224 [No Abstract] [Full Text] [Related]
12. Why the European Parliament rejected the patenting of human genes. Grace M Gene Ther; 1995 Oct; 2(8):509-11. PubMed ID: 8593600 [No Abstract] [Full Text] [Related]
13. To patent or not to patent: the European Union's new biotech directive. Nenow L Houst J Int Law; 2001; 23(3):569-607. PubMed ID: 12769115 [No Abstract] [Full Text] [Related]
14. Much ado about gene patents: the role of foreseeability. Gulliford MJ Seton Hall Law Rev; 2004; 34(2):711-45. PubMed ID: 15115032 [No Abstract] [Full Text] [Related]
15. Patents on parts of the human body: salient issues under EC and WTO law. Herdegen M J World Intellect Prop; 2002 Mar; 5(2):145-55. PubMed ID: 15986546 [No Abstract] [Full Text] [Related]
16. [No to patents for genetic diagnostics]. Lundsteen C Ugeskr Laeger; 2000 Jun; 162(25):3620-1. PubMed ID: 11016292 [No Abstract] [Full Text] [Related]
17. Diagnostics firms face new patent claim worries. Allison M Nat Biotechnol; 2009 Jul; 27(7):586-7. PubMed ID: 19587651 [No Abstract] [Full Text] [Related]
18. [Diffuse rules on patent protection of genes. Scientists risk retroactive payment requirements]. Orn P Lakartidningen; 2000 Nov; 97(46):5285-6. PubMed ID: 11116864 [No Abstract] [Full Text] [Related]
20. [Opposition to Myriad Genetics patents and their total or partial revocation in Europe: early conclusions]. Cassier M; Stoppa-Lyonnet D Med Sci (Paris); 2005; 21(6-7):658-62. PubMed ID: 15985212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]